OpenAI acquires startup Orchestra Bio to beef up its biotech business
Summary
OpenAI has purchased the startup Orchestra Bio to strengthen its biotechnology division. The company will integrate the acquired team and technology into its life sciences AI model, Rosalind, and the related Workbench tool designed to assist researchers.
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Source: Read the full story at TechCrunch
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.